A very rare case of encephalopathy in a patient with end-stage renal disease: contrast agent, ioversol

Ozelsancak R., Erken E., Yildiz I. , Giray S., Yildirim T., Micozkadioglu H.

RENAL FAILURE, cilt.32, ss.1128-1130, 2010 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 32 Konu: 9
  • Basım Tarihi: 2010
  • Doi Numarası: 10.3109/0886022x.2010.510613
  • Dergi Adı: RENAL FAILURE
  • Sayfa Sayıları: ss.1128-1130


Contrast agents are associated with a number of adverse effects, including central nervous system effects. These agents are primarily filtered and excreted by the kidney. Contrast-associated encephalopathy is a rare complication. We report the case of a 55-year-old male on chronic hemodialysis who developed confusion and agitation after receiving ioversol during abdominal angiography. Although hemodialysis was performed his healing took 15 days. Patients with end-stage renal disease may be at an increased risk of adverse effects of contrast agents.